Dave Merola, PharmD, PhD, is a seasoned professional in the field of pharmacoepidemiology and pharmacoeconomics. Experience includes serving as a Research Trainee in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital from December 2020 to January 2022. Currently, Dave Merola holds the position of Senior Advisor in Pharmacoepidemiology at Eli Lilly and Company since April 2024. Additionally, in a brief role at Aetion from March to April 2024, Dave Merola was the Director of Biostatistics and also held positions as Senior Scientist and Associate Director, Biostatistics. Education credentials include a Doctor of Pharmacy from Shenandoah University and a Doctor of Philosophy in Epidemiology with a minor in Biostatistics and a concentration in Pharmacoepidemiology from Harvard University Graduate School of Arts and Sciences.
This person is not in the org chart
This person is not in any teams
This person is not in any offices